Dr. Erdmann Flindt
CEO
Corinna Horn
CEO & CMO
With our state-of-the-art laboratory analyses and powerful proprietary AI algorithms, we have established ourselves as a reliable partner for customers from industry and research worldwide. In an interdisciplinary team, we develop custom-fit solutions that far surpass the status quo. We always strive for win-win situations.
Biomarkers are molecules in the organism that provide information about biological states, e.g. disease, prognosis, prediction of drug efficacy.
In its proprietary AI engine, OakLabs combines several relevant molecules into one biomarker. The readings of each molecule flow into a complex mathematical model and provide results with unique precision.
Our artificial intelligence engine combines a set of proprietary algorithms to develop highly accurate biomarkers for a variety of healthcare applications. We work with customers worldwide in industry and research at the frontier of what is possible.
For a healthier longer life. In 2023, we started to making our state-of-the-art analysis available to individuals. Our science-based health monitor can help with achieving health goals. It provides regular analysis of the amino acid profile in the blood and detects critical health conditions even before symptoms arise. In cooperation with MembraPure we have the possibility to perform the analyses in our in-house laboratory with established technology. Based on the results, customers will receive a personalized report with personalized recommendations that can help leading a healthier life.
We are able to obtain robust data on global gene expression using our experimentally validated microarrays. This allows us to gain deep insights into biological processes and changes. Our complex data analysis makes it easier for our customers to extract new insights from the vast amounts of data.